Physician profile
Razak Dosani
NPI 1699832949
$1,402.27
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $243 · 2021: $35.44 · 2022: $22.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $279.64 | 2019-2020 | |
| Allergan, INC. | $203.99 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $162.63 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $150.81 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $68.77 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.18 | 2019-2020 | |
| Insmed, INC. | $54.05 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $44.80 | 2019 | |
| Philips North America LLC | $44.33 | 2019 | |
| Electromed, INC. | $35.17 | 2019 | |
| Paratek Pharmaceuticals, INC. | $32.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.85 | 2019-2020 | |
| Advanced Respiratory, INC | $28.75 | 2019 | |
| Stryker Corporation | $23.88 | 2021 | |
| Mylan Specialty L.P. | $23.48 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $23.41 | 2019 | |
| Grifols USA, LLC | $23.21 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.95 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.59 | 2020 | |
| La Jolla Pharmaceutical Company | $16.65 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.97 | 2020 | |
| Gilead Sciences, INC. | $14.52 | 2019 | |
| Veran Medical Technologies, INC. | $14.28 | 2019 | |
| Pfizer INC. | $11.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Razak Dosani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.